Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2015).
Articles in this Issue were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence.
Articles are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Sci. Pharm. 2010, 78(3), 655; https://doi.org/10.3797/scipharm.cespt.8.PMS28 (registering DOI)
Novel Approach in Formulation of Low Soluble Drugs: Gliclazide as Model Substance
Institute of Pharmaceutical Technology, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia
Author to whom correspondence should be addressed.
Received: 12 July 2010 / Accepted: 12 July 2010 / Published: 12 July 2010
Abstract The study demonstrates two approaches in formulation of solid self-emulsifying drug delivery systems (SSEDDS) of gliclazide (BCS class II drug). [...]
This is an open access article distributed under the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
Share & Cite This Article
MDPI and ACS Style
JOVIĆ, M.; JEZDIĆ, M.; PETROVIĆ, J.; IBRIĆ, S. Novel Approach in Formulation of Low Soluble Drugs: Gliclazide as Model Substance. Sci. Pharm. 2010, 78, 655.
JOVIĆ M, JEZDIĆ M, PETROVIĆ J, IBRIĆ S. Novel Approach in Formulation of Low Soluble Drugs: Gliclazide as Model Substance. Scientia Pharmaceutica. 2010; 78(3):655.
JOVIĆ, M.; JEZDIĆ, M.; PETROVIĆ, J.; IBRIĆ, S. 2010. "Novel Approach in Formulation of Low Soluble Drugs: Gliclazide as Model Substance." Sci. Pharm. 78, no. 3: 655.
Show more citation formats
Show less citations formats
[Return to top]
For more information on the journal statistics, click here
Multiple requests from the same IP address are counted as one view.